SkinBioTherapeutics plc (SBTX) Ord GBP0.01
- Add to watchlist
- Create an alert
- This stock can be held in a
15.88p
16.07p
19.40p
£36.26 million
15.88p
15.86p
7.25p
n/a
0.13p (0.78%) Previous:
0.13p
165,889
n/a
30,000
Performance
Not available for this stock.
Fundamental data
Year ending: | 30/06/2023 | 30/06/2022 |
---|---|---|
Revenue (£m) | 0.13 | 0.07 |
Profit before tax (£m) | (3.01) | (2.99) |
Adjusted EPS (p): | (1.72) | (1.78) |
P/E ratio | n/a | n/a |
PEG | n/a | n/a |
EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
SkinBioTherapeutics shares jump on acquisition of topical cream maker
11 October 2024 08:41
-
SkinBioTherapeutics reports positive results from testing with Croda
19 September 2024 13:13
-
SkinBioTherapeutics secures £1.56m from new investors
2 August 2024 14:57
-
Finalisation of commercial agreement with Croda
19 November 2024 07:00
-
Holding(s) in Company
25 October 2024 16:29
-
Integration update and share price movement
23 October 2024 14:40
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.